Topical Corticosteroids Market

By Type Of Formulation;

Ointments, Creams and Others

By Type Of Potency Class;

Ultra High-[Clobetasol Propionate and Diflorasone Diacetate], High-[Amcinonide, Betamethasone Dipropionate, Desoximetasone, Fluocinonide, Halcinonide and Others], Moderate-[Desoximetasone, Fluocinolone Acetonide, Fludroxycortide, Hydrocortisone Valerate, Triamcinolone Acetonide and Others], Low-[ Betamethasone Valerate, Desonide, Fluocinolone Acetonide and Others]

By Route of Administration;

Topical Application and Transdermal

By Type Of Treatment;

Contact Dermatitis, Insect Stings, Psoriasis, Eczema and Others

By End User;

Hospitals & Clinics, Dermatology Clinics, Pharmacies and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn799531494 Published Date: August, 2025 Updated Date: September, 2025

Topical Corticosteroids Market Overview

Topical Corticosteroids Market (USD Million)

Topical Corticosteroids Market was valued at USD 4,494.07 million in the year 2024. The size of this market is expected to increase to USD 6,421.21 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.2%.


Topical Corticosteroids Market

*Market size in USD million

CAGR 5.2 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.2 %
Market Size (2024)USD 4,494.07 Million
Market Size (2031)USD 6,421.21 Million
Market ConcentrationMedium
Report Pages369
4,494.07
2024
6,421.21
2031

Major Players

  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sandoz AG (Novartis AG)
  • Sanofi S.A.
  • Actimis Pharmaceuticals
  • Bausch Health
  • Almirall, S.A
  • Zylera Pharmaceuticals
  • AstraZeneca plc

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Topical Corticosteroids Market

Fragmented - Highly competitive market without dominant players


The Topical Corticosteroids Market is growing consistently as dermatology relies heavily on these treatments for managing inflammatory skin diseases. Over 65% of dermatological prescriptions include corticosteroid-based therapies, underlining their critical role in addressing conditions such as eczema, psoriasis, and dermatitis. Their rapid action and established safety profile make them indispensable in skin care.

Rising Prevalence of Skin Disorders
The rising occurrence of chronic skin disorders has fueled this demand. Approximately 55% of patients with skin-related conditions use topical corticosteroids to relieve symptoms. Their effectiveness in reducing itching, inflammation, and irritation has strengthened their use as frontline therapies in dermatology.

Adoption of Low- and Medium-Potency Formulations
A large proportion of prescriptions involve low- and medium-potency corticosteroids, which represent nearly 50% of clinical use. These options are widely favored due to their balanced efficacy and lower risk of adverse effects, particularly in children and long-term treatment settings.

Advancements in Drug Delivery Systems
Innovation continues to advance the field, with about 45% of new product launches focusing on improved drug delivery formats such as gels, ointments, and creams. These developments improve skin absorption, enhance effectiveness, and support better patient compliance.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type Of Formulation
    2. Market Snapshot, By Type Of Potency Class
    3. Market Snapshot, By Route of Administration
    4. Market Snapshot, By Type Of Treatment
    5. Market Snapshot, By End User
    6. Market Snapshot, By Region
  4. Topical Corticosteroids Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising dermatological conditions
        2. Increasing geriatric population
        3. Growing healthcare awareness
        4. Advancements in formulations
        5. Expanding product availability
      2. Restraints
        1. Side effects concern
        2. Strict regulatory policies
        3. High treatment costs
        4. Limited awareness rural
        5. Competition from alternatives
      3. Opportunities
        1. Emerging markets growth
        2. Product innovation advancements
        3. Online pharmacy expansion
        4. Increasing skincare trends
        5. Government healthcare initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Topical Corticosteroids Market, By Type Of Formulation, 2021 - 2031 (USD Million)
      1. Ointments
      2. Creams
      3. Others
    2. Topical Corticosteroids Market, By Type Of Potency Class, 2021 - 2031 (USD Million)
      1. Ultra High
        1. Clobetasol Propionate
        2. Diflorasone Diacetate
      2. High
        1. Amcinonide
        2. Betamethasone Dipropionate
        3. Desoximetasone
        4. Fluocinonide
        5. Halcinonide
        6. Others
      3. Moderate
        1. Desoximetasone
        2. Fluocinolone Acetonide
        3. Fludroxycortide
        4. Hydrocortisone Valerate
        5. Triamcinolone Acetonide
        6. Others
      4. Low
        1. Betamethasone Valerate
        2. Desonide
        3. Fluocinolone Acetonide
        4. Others
    3. Topical Corticosteroids Market, By Route of Administration, 2021 - 2031 (USD Million)

      1. Topical Application

      2. Transdermal

    4. Topical Corticosteroids Market, By Type Of Treatment, 2021 - 2031 (USD Million)
      1. Contact Dermatitis
      2. Insect Stings
      3. Psoriasis
      4. Eczema
      5. Others
    5. Topical Corticosteroids Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals & Clinics
      2. Dermatology Clinics
      3. Pharmacies
      4. Others
    6. Topical Corticosteroids Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. AstraZeneca plc
      2. GlaxoSmithKline plc
      3. Merck & Co., Inc.
      4. Pfizer Inc.
      5. Sandoz AG (Novartis AG)
      6. Sanofi S.A.
      7. Actimis Pharmaceuticals
      8. Bausch Health
      9. Almirall, S.A
      10. Zylera Pharmaceuticals
      11. AstraZeneca plc
  7. Analyst Views
  8. Future Outlook of the Market